COLLPLANT BIOTECH. IS-01 (CPT) — Capital Reinvestment Ratio

Latest as of December 2021: 0.64x

COLLPLANT BIOTECH. IS-01 (CPT) has a Capital Reinvestment Ratio of 0.64x as of December 2021, meaning it reinvests 1% of its operating cash flow (€2.50 Million) in capital expenditures (€1.59 Million). See CPT equity to assets ratio to measure how much of total assets are equity-financed.

Capital Reinvestment Ratio

0.64x
Capex / Operating Cash Flow

Operating Cash Flow

€2.50 Million
EUR

Capital Expenditures

€1.59 Million
EUR

Data as of

Dec 2021
Most recent filing

COLLPLANT BIOTECH. IS-01 Capital Reinvestment Ratio (2021–2021)

This chart tracks COLLPLANT BIOTECH. IS-01's Capital Reinvestment Ratio across 1 annual periods. Check CPT total capital reinvestment ratio to assess the company's total reinvestment commitment from operating cash flow.

Annual Capital Reinvestment Ratio for COLLPLANT BIOTECH. IS-01 (2021–2021)

Year-by-year Capital Reinvestment Ratio for COLLPLANT BIOTECH. IS-01 from 2021 to 2021. For live market cap and broader valuation context, see COLLPLANT BIOTECH. IS-01 market capitalisation.

Year Reinvestment Ratio Operating CF (EUR) Capital Expenditures YoY Change
2021 0.64x €2.50 Million €1.59 Million
Capital Reinvestment Ratio = ABS(Capital Expenditures) / Operating Cash Flow